Metabolomics and lipidomics in the differentiation of CIN 2 and CIN 3: an exploratory pilot study
INTRODUCTION: High-grade cervical intraepithelial neoplasia (CIN 2-3) is a precursor lesion to cervical cancer and, although it presents different probabilities of regression and progression, it is usually grouped together in screening and managed similarly. However, the mechanisms that determine its evolution are still poorly understood, and standard treatment by conization can lead to reproductive complications such as subfertility and premature birth. OBJECTIVE: This study aimed to identify metabolic and lipid signatures that can distinguish between CIN 2 and CIN 3 lesions using liquid chromatography-high-resolution mass spectrometry (LC-HRMS). METHODS: Tissue samples from the lesion and adjacent margin of 24 women with CIN 2-3 were subjected to metabolomic and lipidomic analysis by LC-HRMS. Multivariate statistical analyses, pathway analysis, and correlation were performed to understand these neoplasms' development and progression and identify potential metabolites and lipids to distinguish such lesions. RESULTS: Metabolomic and lipidomic analysis by LC-HRMS in cervical tissue identified molecular signatures with differential abundance between CIN 2 and CIN 3, highlighting patterns associated with the degree of lesion. Multivariate analyses highlighted metabolites (serine, glutamic acid, guanidine-6-monophosphate, succinic acid, mannose 6-phosphate, and taurine) and lipids (TG 49:1, TG 50:1, and TG 52:2) as the main contributors to the discrimination between the groups, suggesting relevant biological alterations in high-grade cervical lesions. CONCLUSION: Combination metabolomic and lipidomic approach enabled the identification of metabolites and lipids potentially involved in the pathogenesis of intraepithelial neoplasia (CINs). In addition, these identified metabolite and lipid panels are promising as complementary tools for future screening strategies for these lesions.
Authors
- Adriano de Souza Carolino (ORCID: https://orcid.org/0000-0003-2284-4805)
- Priscila Ferreira de Aquino (ORCID: https://orcid.org/0000-0002-2344-0493)
- Elzalina Ribeiro Soares (ORCID: https://orcid.org/0000-0002-9267-8841)
- Rafael Garrett (ORCID: https://orcid.org/0000-0002-5823-311X)
- Luana Quadros de S. Leão (ORCID: https://orcid.org/0000-0002-8085-1248)
- Anderson Ferreira Gonçalves
- Giovanna Melo Marques (ORCID: https://orcid.org/0009-0002-8775-9572)
- Sofia Angiole Cavalcante (ORCID: https://orcid.org/0000-0001-8602-3577)
- Marina Amaral Alves (ORCID: https://orcid.org/0000-0002-8188-5554)
- Ana Carolina Rosa da Silva
- Jonas Balan de Padua
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Hospital for Sick Children (CA)
- Universidade do Estado do Amazonas (BR)
- Fiocruz Amazônia (BR)
- Fundação Oswaldo Cruz (BR)
- Universidade Federal do Amazonas (BR)
Publication Details
- Journal
- Metabolomics
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1007/s11306-026-02555-w
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado do Amazonas
- Fundação Oswaldo Cruz